Cash incentives to improve insulin dosing in youth with Type 1 Diabetes
Behavioral Incentive Meal Dose Engagement in Adolescents With Type 1 Diabetes
This study is testing if cash rewards can help teenagers with Type 1 Diabetes remember to take their insulin at mealtimes to better control their blood sugar.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 36 (estimated) |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Sponsor | Children's Mercy Hospital Kansas City Academic / other |
| Locations | 1 site (Kansas City, Kansas) |
| Trial ID | NCT04621890 on ClinicalTrials.gov |
What this trial studies
This study evaluates two behavioral economic interventions aimed at improving mealtime insulin dosing in adolescents with Type 1 Diabetes (T1D). Participants aged 12-17 will be randomized into three groups: one receiving cash incentives (COIN2DOSE), another receiving a loan-based incentive (LOAN2DOSE), and a control group. The interventions will utilize an automated meal detection device and economic incentives to encourage adherence to insulin dosing. The goal is to enhance glycemic control by addressing the common issue of missed insulin doses during meals.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 12-17 with a diagnosis of Type 1 Diabetes for at least six months and a current A1C greater than 7.2%.
Not a fit: Patients with diabetes types other than Type 1 or those with conditions affecting A1C levels may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve blood sugar control and overall health outcomes for adolescents with Type 1 Diabetes.
How similar studies have performed: While behavioral economic interventions in diabetes care are emerging, this specific approach combining cash incentives and automated meal detection is innovative and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 12-17.99 years * The youth must have been diagnosed with T1D for at least 6 months * The youth must have attended at least 2 routine T1D standard of care visits in the past 12 months * The youth must be using an insulin delivery device capable of recording, storing, and downloading insulin bolus behaviors (insulin pump or smart Bluetooth insulin pen that can be uploaded to standard clinic upload software). * The youth must have a current A1C \>7.2% and/or be predicted to have a rise in A1C in of 0.3% or higher the next 90 days. * Not pregnant or planning to become pregnant by self-report. Exclusion Criteria: * Participants with any type of diabetes mellitus other than T1D * Participant has any disease causing anemia or affecting red blood cell physiology (which would impact A1C) * Participant has a physical disability, which in the opinion of the investigator would interfere with individual's ability to feed themselves or use one's hands to facilitate eating * Participants with no internet access or ability to upload device(s) to data aggregation software that is accessible to study team. For Focus Groups: Any parent or legal guardian whose child is eligible for the study is invited to participate in a focus group discussion.
Where this trial is running
Kansas City, Kansas
- Children's Mercy Kansas City — Kansas City, Kansas, United States (Recruiting)
Study contacts
- Study coordinator: Sarah Tsai, MD
- Email: sltsai@cmh.edu
- Phone: (816) 960-8952
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.